🇺🇸 Non-steroidal anti-inflammatory drugs in United States

32 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Drug Ineffective — 5 reports (15.62%)
  2. Apnoea — 4 reports (12.5%)
  3. Arthralgia — 3 reports (9.38%)
  4. Back Pain — 3 reports (9.38%)
  5. Diarrhoea — 3 reports (9.38%)
  6. Leukopenia — 3 reports (9.38%)
  7. Oxygen Saturation Decreased — 3 reports (9.38%)
  8. Pyrexia — 3 reports (9.38%)
  9. Renal Failure Acute — 3 reports (9.38%)
  10. Abdominal Distension — 2 reports (6.25%)

Source database →

Non-steroidal anti-inflammatory drugs in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Non-steroidal anti-inflammatory drugs approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Non-steroidal anti-inflammatory drugs in United States?

Cairo University is the originator. The local marketing authorisation holder may differ — check the official source linked above.